Health ❯Healthcare ❯Drug Development

Regulatory Affairs

FDA Submissions FDA Approval Drug Discontinuation

GSK Agrees to $2.2 Billion Settlement Over Zantac Cancer Claims

Alnylam's Vutrisiran Shows Mixed Results in Cardiomyopathy Study